Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 676 | -116 | -1,243 | -2,157 |
| Depreciation Amortization | N/A | 1,784 | 6,851 | 5,023 | 3,381 |
| Other Working Capital | N/A | 0 | -2,104 | -1,321 | -1,696 |
| Other Operating Activity | 0 | -4,875 | 3,232 | 368 | 3,070 |
| Operating Cash Flow | $N/A | $-2,415 | $7,863 | $2,827 | $2,598 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2,460 | -7,306 | -4,903 | -2,940 |
| Net Acquisitions | N/A | 0 | -2,034 | -2,034 | -2,109 |
| Other Investing Activity | 0 | -2,072 | -7,871 | -6,147 | -7,305 |
| Investing Cash Flow | $N/A | $-4,532 | $-17,211 | $-13,084 | $-12,354 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -24 | -2,589 | -1,480 | -631 |
| Financing Cash Flow | $N/A | $-24 | $-2,589 | $-1,480 | $-631 |
| Beginning Cash Position | N/A | 13,475 | 25,412 | 25,412 | 25,412 |
| End Cash Position | N/A | 6,504 | 13,475 | 13,675 | 15,025 |
| Net Cash Flow | $N/A | $-6,971 | $-11,937 | $-11,737 | $-10,387 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -2,415 | 7,863 | 2,827 | 2,598 |
| Free Cash Flow | 0 | -2,415 | 7,863 | 2,827 | 2,598 |